These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 16825812)

  • 41. Relationship of tumor angiogenesis and nuclear p53 accumulation in invasive bladder cancer.
    Bochner BH; Esrig D; Groshen S; Dickinson M; Weidner N; Nichols PW; Skinner DG; Cote RJ
    Clin Cancer Res; 1997 Sep; 3(9):1615-22. PubMed ID: 9815851
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tissue microarray analysis of the prognostic value of E-cadherin, Ki67, p53, p27, survivin and MSH2 expression in upper urinary tract transitional cell carcinoma.
    Fromont G; Rouprêt M; Amira N; Sibony M; Vallancien G; Validire P; Cussenot O
    Eur Urol; 2005 Nov; 48(5):764-70. PubMed ID: 16126329
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Relationship of cytokeratin 20 and CD44 protein expression with WHO/ISUP grade in pTa and pT1 papillary urothelial neoplasia.
    Desai S; Lim SD; Jimenez RE; Chun T; Keane TE; McKenney JK; Zavala-Pompa A; Cohen C; Young RH; Amin MB
    Mod Pathol; 2000 Dec; 13(12):1315-23. PubMed ID: 11144928
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Recurrence, progression and success in stage Ta grade 3 bladder tumors treated with low dose bacillus Calmette-Guerin instillations.
    Lebret T; Bohin D; Kassardjian Z; Herve JM; Molinie V; Barre P; Lugagne PM; Botto H
    J Urol; 2000 Jan; 163(1):63-7. PubMed ID: 10604315
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The p53 positivity in non-tumor mucosa in patients with superficial urinary bladder cancer].
    Soukup V; Babjuk M; Dusková J; Pesl M; Szakácsova M; Zámefnik L; Dvorácek J
    Cas Lek Cesk; 2007; 146(1):63-7. PubMed ID: 17310587
    [TBL] [Abstract][Full Text] [Related]  

  • 46. P53 accumulation, deoxyribonucleic acid ploidy and progression of bladder cancer.
    Raitanen MP; Tammela TL; Kallioinen M; Isola J
    J Urol; 1997 Apr; 157(4):1250-3. PubMed ID: 9120913
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Biologic differences between noninvasive papillary urothelial neoplasms of low malignant potential and low-grade (grade 1) papillary carcinomas of the bladder.
    Pich A; Chiusa L; Formiconi A; Galliano D; Bortolin P; Navone R
    Am J Surg Pathol; 2001 Dec; 25(12):1528-33. PubMed ID: 11717543
    [TBL] [Abstract][Full Text] [Related]  

  • 48. E-cadherin expression as a prognostic factor in transitional cell carcinoma of the bladder after transurethral resection.
    Khorrami MH; Hadi M; Gharaati MR; Izadpanahi MH; Javid A; Zargham M
    Urol J; 2012; 9(3):581-5. PubMed ID: 22903481
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ki-67 index enhances the prognostic accuracy of the urothelial superficial bladder carcinoma risk group classification.
    Santos L; Amaro T; Costa C; Pereira S; Bento MJ; Lopes P; Oliveira J; Criado B; Lopes C
    Int J Cancer; 2003 Jun; 105(2):267-72. PubMed ID: 12673690
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Histologic grading of urothelial carcinoma: a reappraisal.
    Cheng L; MacLennan GT; Lopez-Beltran A
    Hum Pathol; 2012 Dec; 43(12):2097-108. PubMed ID: 22542126
    [TBL] [Abstract][Full Text] [Related]  

  • 51. PCNA and p53 in urinary bladder cancer: correlation with histological findings and prognosis.
    Inagaki T; Ebisuno S; Uekado Y; Hirano A; Hiroi A; Shinka T; Ohkawa T
    Int J Urol; 1997 Mar; 4(2):172-7. PubMed ID: 9179692
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Superficial papillary urothelial neoplasms of the bladder (PTA E PT1): correlation of expression of P53, KI-67 and CK20 with histologic grade, recurrence and tumor progression.
    Ogata DC; Marcondes CA; Tuon FF; Busato WF; Cavalli G; Czeczko LE
    Rev Col Bras Cir; 2012; 39(5):394-400. PubMed ID: 23174791
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expression of cell-cycle regulatory proteins and their prognostic value in superficial low-grade urothelial cell carcinoma of the bladder.
    Santos LL; Amaro T; Pereira SA; Lameiras CR; Lopes P; Bento MJ; Oliveira J; Criado B; Lopes CS
    Eur J Surg Oncol; 2003 Feb; 29(1):74-80. PubMed ID: 12559081
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Low-grade papillary urothelial carcinoma of the urinary bladder: a clinicopathologic analysis of a post-World Health Organization/International Society of Urological Pathology classification cohort from a single academic center.
    Miyamoto H; Brimo F; Schultz L; Ye H; Miller JS; Fajardo DA; Lee TK; Epstein JI; Netto GJ
    Arch Pathol Lab Med; 2010 Aug; 134(8):1160-3. PubMed ID: 20670136
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Overexpression of c-met as a prognostic indicator for transitional cell carcinoma of the urinary bladder: a comparison with p53 nuclear accumulation.
    Cheng HL; Trink B; Tzai TS; Liu HS; Chan SH; Ho CL; Sidransky D; Chow NH
    J Clin Oncol; 2002 Mar; 20(6):1544-50. PubMed ID: 11896103
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Clinicopathological study of the 1973 who classification and the WHO/ISUP classification in pTa bladder carcinoma].
    Ishida R; Tsuzuki T; Yoshida S; Shiota T; Nisikimi T; Yamada H; Yokoi K; Kobayashi H
    Nihon Hinyokika Gakkai Zasshi; 2010 May; 101(4):609-14. PubMed ID: 20535989
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Does muscularis mucosae invasion in extensively lamina propria-invasive high-grade papillary urothelial carcinoma provide additional prognostic information?
    Pan CC
    Am J Surg Pathol; 2013 Mar; 37(3):459-60. PubMed ID: 23388127
    [No Abstract]   [Full Text] [Related]  

  • 58. Impact of p53 and Ki-67 in predicting recurrence and progression of superficial (pTa and pT1) urothelial cell carcinomas of urinary bladder.
    Kilicli-Camur N; Kilicaslan I; Gulluoglu MG; Esen T; Uysal V
    Pathol Int; 2002 Jul; 52(7):463-9. PubMed ID: 12167105
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of P53 protein overexpression, Ki67 proliferative activity and mitotic index as markers of tumour recurrence in superficial transitional cell carcinoma of the bladder.
    Gontero P; Casetta G; Zitella A; Ballario R; Pacchioni D; Magnani C; Muir GH; Tizzani A
    Eur Urol; 2000 Sep; 38(3):287-96. PubMed ID: 10940702
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of WHO 1973, WHO/ISUP 1998, WHO 1999 grade and combined scoring systems in evaluation of bladder carcinoma.
    Bircan S; Candir O; Serel TA
    Urol Int; 2004; 73(3):201-8. PubMed ID: 15539837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.